Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Link opens in a new tab
Search content at Tel Aviv University
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Chapter 11 Antiphospholipid Antibodies, Infections, and Drugs
Miri Blank
,
Gisele Zandman Goddard
, Yaniv Sherer
,
Yehuda Shoenfeld
*
*
Corresponding author for this work
Sheba Medical Center at Tel Hashomer
Edith Wolfson Medical Center Israel
Tel Aviv Sourasky Medical Center
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Chapter 11 Antiphospholipid Antibodies, Infections, and Drugs'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chapter 11
100%
Antiphospholipid Antibodies
100%
Antiphospholipid Syndrome
62%
Molecular Mimicry
25%
β2-glycoprotein I (β2GPI)
25%
Virus
12%
Vaccination
12%
Drug-induced
12%
Clinical picture
12%
Central Nervous System
12%
Thrombosis
12%
Infectious Agents
12%
Microbial Infection
12%
Synthetic Peptides
12%
Syndrome Model
12%
Tetanus Toxoid
12%
Cytomegalovirus
12%
Recurrent Fetal Loss
12%
Organ Involvement
12%
Autoreactive Lymphocyte
12%
Synthetic Structure
12%
Neuroscience
Phospholipid Antibody
100%
Antiphospholipid Syndrome
62%
Glycoprotein
25%
Central Nervous System
12%
Synthetic Peptide
12%
Cytomegalovirus
12%
Tetanus Vaccine
12%
Lymphocyte
12%
Biochemistry, Genetics and Molecular Biology
Antiphospholipid Antibody
100%
Antiphospholipid Syndrome
62%
Glycoprotein
25%
Molecular Mimicry
25%
Infectious Agent
12%
Cytomegalovirus
12%
Lymphocyte
12%